We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$4.26B
AUM Growth
-$20.1M
Cap. Flow
-$50.3M
Cap. Flow %
-1.18%
Top 10 Hldgs %
30.91%
Holding
425
New
29
Increased
142
Reduced
157
Closed
18

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$26.3M
2
NDSN icon
Nordson
NDSN
+$6.48M
3
AVGO icon
Broadcom
AVGO
+$6.19M
4
COP icon
ConocoPhillips
COP
+$5.55M
5
ISRG icon
Intuitive Surgical
ISRG
+$3.83M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$19.3M
2
DE icon
Deere & Co
DE
+$5.46M
3
MSFT icon
Microsoft
MSFT
+$5.11M
4
MRCY icon
Mercury Systems
MRCY
+$4.37M
5
BABA icon
Alibaba
BABA
+$3.21M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 17.37%
3 Financials 11.62%
4 Industrials 9.59%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTB icon
326
M&T Bank
MTB
$36.3B
$406K 0.01%
2,716
+133
+5% +$18.4K
IWD icon
327
iShares Russell 1000 Value ETF
IWD
$84.2B
$405K 0.01%
2,588
-94
-4% -$15.1K
COLD icon
328
Americold
COLD
$4.17B
$402K 0.01%
13,850
-14,497
-51% -$531K
CDXS icon
329
Codexis
CDXS
$161M
$401K 0.01%
17,229
BNL icon
330
Broadstone Net Lease
BNL
$3.93B
$389K 0.01%
15,695
RXST icon
331
RxSight
RXST
$273M
$389K 0.01%
+30,678
New +$422K
VRTX icon
332
Vertex Pharmaceuticals
VRTX
$133B
$387K 0.01%
2,134
-98,754
-98% -$19.3M
BR icon
333
Broadridge
BR
$19.8B
$386K 0.01%
2,314
+2
+0.1% +$341
WEC icon
334
WEC Energy
WEC
$34.6B
$381K 0.01%
4,316
FIS icon
335
Fidelity National Information Services
FIS
$21.9B
$379K 0.01%
3,113
ADM icon
336
Archer Daniels Midland
ADM
$38.8B
$377K 0.01%
6,280
+570
+10% +$34.2K
SPG icon
337
Simon Property Group
SPG
$71.5B
$377K 0.01%
+2,901
New +$378K
TSLA icon
338
Tesla
TSLA
$1.31T
$375K 0.01%
1,452
-894
-38% -$210K
VOT icon
339
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.7B
$367K 0.01%
1,555
BKNG icon
340
Booking.com
BKNG
$160B
$366K 0.01%
3,850
ETN icon
341
Eaton
ETN
$173B
$361K 0.01%
2,418
+1
+0% +$160
IUSV icon
342
iShares Core S&P US Value ETF
IUSV
$27.8B
$361K 0.01%
+5,087
New +$369K
HP icon
343
Helmerich & Payne
HP
$4.18B
$359K 0.01%
13,100
-3,150
-19% -$87.9K
CLX icon
344
Clorox
CLX
$13B
$358K 0.01%
2,163
+19
+0.9% +$3.27K
SLB icon
345
SLB Ltd
SLB
$78.9B
$352K 0.01%
11,861
-522
-4% -$15K
PEG icon
346
Public Service Enterprise Group
PEG
$37.2B
$350K 0.01%
5,748
-2,700
-32% -$169K
XLV icon
347
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$349K 0.01%
+2,744
New +$363K
REGN icon
348
Regeneron Pharmaceuticals
REGN
$83.2B
$346K 0.01%
571
+62
+12% +$38.5K
SJM icon
349
J.M. Smucker
SJM
$12.6B
$340K 0.01%
2,836
-9
-0.3% -$1.14K
AMAT icon
350
Applied Materials
AMAT
$415B
$337K 0.01%
2,619
+10
+0.4% +$1.36K

Similar funds

Bradley Foster & Sargent's Q3 2021 Portfolio in Review

As of Q3 2021, Bradley Foster & Sargent held 425 positions worth $4.26B, down 0.47% from $4.28B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bradley Foster & Sargent's Q3 2021 filing shows 29 new, 142 increased, 157 reduced and 18 closed positions. Its largest new stake was Broadcom: 127,340 shares worth $6.17M. The largest sale was Vertex Pharmaceuticals, an estimated $19.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bradley Foster & Sargent's largest Q3 2021 buy was Broadcom: 127,340 shares worth $6.17M.
  • Bradley Foster & Sargent added most to Oracle in Q3 2021, an estimated $26.3M increase.
  • Bradley Foster & Sargent's biggest Q3 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $19.3M.
  • Bradley Foster & Sargent fully exited Mercury Systems in Q3 2021, selling an estimated $4.37M.
  • Bradley Foster & Sargent's ten largest holdings make up 31% of its $4.26B portfolio in Q3 2021.
  • Bradley Foster & Sargent opened 29 new positions and closed 18 in Q3 2021.
  • Bradley Foster & Sargent's portfolio value fell 0.47% quarter-over-quarter to $4.26B.

Based on Bradley Foster & Sargent's 13F filing for Q3 2021, filed 10 Nov 2021.